4 Results for "

AG129 mice

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "AG129 mice" in MCE Product Catalog:

Cat. No.: HY-136782
CAS No.: 390803-40-4
Purity:  ≥99.0%
Target:  

Flavivirus Dengue Virus

Research Areas:  

Infection

ST-148 maleate is a potent and orally active DENV inhibitor. ST-148 maleate shows antiviral efficacy and low cell toxicity. ST-148 alters the interaction between lipid droplets and the C protein, thereby inhibiting viral replication. .
loading...
    loading...
Cat. No.: HY-184899
Target:  

Sirtuin CXCR Dengue Virus

Research Areas:  

Infection Inflammation/Immunology

Sirt1/CXCR3-IN-1 is a dual Sirt1/CXCR3 inhibitor with an IC50 of 0.77 μM against Sirt1. Sirt1/CXCR3-IN-1 inhibits dengue virus replication, upregulates the expression of interferon-stimulated genes, and enhances the antiviral defense capacity of the host. Sirt1/CXCR3-IN-1 suppresses CXCR3-mediated T cell chemotaxis and cytokine release, thereby reducing immune activation and inflammatory responses. Sirt1/CXCR3-IN-1 is applicable to research related to dengue virus infection .
loading...
    loading...
Cat. No.: HY-184226A
Target:  

Virus Protease

Research Areas:  

Infection

ASAP-0036543 is an orally active virus NS2B-NS3 protease inhibitor. ASAP-0036543 exhibits activity againse Zika virus (ZIKV) and West Nile virus (WNV). ASAP-0036543 reduces ZIKV RNA load in plasma and spleen, and inhibits ZIKV and WNV replication in mammalian cells. ASAP-0036543 can be used for the research of zika virus infection, west nile virus infection .
loading...
    loading...
Cat. No.: HY-181991
CAS No.: 3014840-61-7
Research Areas:  

Infection

IRBM-Z-2 is a non-competitive, orally active Zika virus (ZIKV) NS2B-NS3 protease inhibitor, with IC50 values of 0.04 μM and 3.1 μM against the wild-type and I156T mutant strains, respectively. IRBM-Z-2 exhibits broad-spectrum anti-flavivirus potential, with IC50 values of 2.1 μM and 0.09 μM against the NS2B-NS3 proteases of dengue virus 2 (DENV2) and West Nile virus (WNV), respectively. IRBM-Z-1 inhibits ZIKV replication and alleviates virus-induced cytopathic effects. IRBM-Z-1 can be used in studies related to ZIKV infection .
loading...
    loading...